Every Form 4 that Hillenbrand, Inc. (HI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow HI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HI filings page.
Hillenbrand, Inc. reported insider equity transactions by senior vice president, general counsel and secretary Nicholas R. Farrell. On 12/05/2025, he acquired 2,492 shares of common stock at $31.82 per share through an option exercise and had 1,068 shares disposed of at $31.82 per share, leaving 70,723 shares of common stock held directly. On 12/04/2025, he was also granted 29,874 Restricted Stock Units, each representing one share of common stock, with dividend equivalent rights. These RSUs are scheduled to vest in three equal installments on 12/4/2026, 12/4/2027, and 12/4/2028.
Hillenbrand, Inc. officer reports stock transactions and new RSU grant. Senior Vice President and Chief Procurement Officer Carole Anne Phillips reported activity in Hillenbrand common stock and restricted stock units on 12/04/2025 and 12/05/2025. She acquired 956 shares of common stock at $31.82 per share and had 417 shares withheld at the same price to cover obligations, leaving her with 5,635 shares of common stock held directly.
Phillips also received a new award of 11,006 restricted stock units on 12/04/2025. Each unit represents the right to receive one share of common stock and carries dividend equivalent rights that accrue on dividend record dates. These units are scheduled to vest in three installments: one-third on 12/4/2026, one-third on 12/4/2027, and one-third on 12/7/2028, subject to the award terms.
Hillenbrand, Inc. reported insider equity activity by its President and CEO, Kimberly K. Ryan. On 12/05/2025, she acquired 16,700 shares of common stock through a transaction coded "M" at a price of $31.82 per share, increasing her directly held stake to 190,703.745 shares before a same‑day disposition. She then disposed of 4,965 shares in a transaction coded "F" at $31.82 per share, leaving 185,738.745 shares of common stock held directly.
The filing also shows a new grant of 182,389 Restricted Stock Units dated 12/04/2025. Each unit represents the right to receive one share of Hillenbrand common stock and carries dividend equivalent rights that accrue on dividend record dates. These units are scheduled to vest in three equal installments on 12/4/2026, 12/4/2027, and 12/4/2028, aligning the CEO’s compensation with long-term company performance.
Hillenbrand, Inc. reported insider equity activity for its Senior Vice President & Chief Information Officer, Bhavik N. Soni. On 12/05/2025, he acquired 1,148 shares of common stock through a transaction coded “M” at $31.82 per share, and disposed of 505 shares in a transaction coded “F” at the same price. After these trades, he beneficially owned 14,035 common shares directly.
The filing also shows a new award of 11,006 Restricted Stock Units (Deferred Stock Award dated 12/04/2025). Each unit represents the right to receive one share of common stock and carries dividend equivalent rights that accrue on dividend record dates. These RSUs are scheduled to vest in three equal installments on 12/04/2026, 12/04/2027, and 12/04/2028, providing a multi‑year equity incentive.
Hillenbrand, Inc. reported insider equity activity for a senior executive. Sr. VP of Strategy & Corporate Development J. Michael Whitted exercised 2,875 shares of common stock on 12/05/2025 at $31.82 per share and had 843 shares withheld at the same price, likely to cover taxes, leaving him with 83,505 directly owned shares afterward.
On 12/04/2025, he also received a grant of 31,446 Restricted Stock Units (RSUs), each representing the right to one share of common stock and accruing dividend equivalents. These RSUs are scheduled to vest in three equal installments on 12/4/2026, 12/4/2027, and 12/4/2028, aligning part of his compensation with the company’s long-term performance.
Hillenbrand, Inc. reported an equity award to an executive officer. Interim CFO, VP, CC, & CAO Megan A. Walke received 7,044 Restricted Stock Units (RSUs) as of 12/04/2025, each representing the contingent right to receive one share of Hillenbrand common stock. These RSUs carry dividend equivalent rights that accrue on dividend record dates, so the award tracks future dividends until shares are delivered.
The RSUs are scheduled to vest in three equal installments: one-third on 12/04/2026, one-third on 12/04/2027, and one-third on 12/04/2028. Following this grant, Walke beneficially owns 4,966 shares of Hillenbrand common stock directly, separate from the RSU award.
Hillenbrand, Inc. reported insider equity transactions by its Sr. VP & President, APS. On 12/05/2025, the executive acquired 3,069 shares of common stock at $31.82 per share through the vesting and settlement of performance-based restricted stock units, then disposed of 1,582 shares at $31.82, typically consistent with tax withholding. Following these transactions, the executive directly beneficially owned 25,666 shares of common stock.
Separately, on 12/04/2025, the executive received a grant of 30,503 restricted stock units, each representing one share of common stock and carrying dividend equivalent rights. These units are scheduled to vest in three equal installments on 12/4/2026, 12/4/2027, and 12/4/2028, providing a long-term equity-based component to the executive’s compensation.
Hillenbrand, Inc. reported an equity award to senior executive Tamara Morytko, Sr. VP & President, MTS. On 12/04/2025, she received 33,647 Restricted Stock Units (RSUs), each representing the right to receive one share of Hillenbrand common stock. These RSUs carry dividend equivalent rights that accrue on dividend record dates, meaning she is credited for dividends as if she already held the underlying shares.
The RSUs are scheduled to vest in three equal installments: one-third on 12/4/2026, one-third on 12/4/2027, and one-third on 12/4/2028. Following this grant, the filing shows 33,647 derivative securities (RSUs) held directly and 5,671 shares of common stock reported as directly owned.
Hillenbrand, Inc. (HI) filed a Form 4/A to correct a prior insider report. The amendment adds the reporting person’s direct ownership, shown as 5,096 shares of common stock. The filer is identified as a Sr. VP & Chief Procurement Officer, and the earliest transaction date is listed as 09/30/2025. The amendment notes an administrative error in the original filed on 10/02/2025 that omitted these direct holdings.
Hillenbrand, Inc. (HI) disclosed an insider transaction by President & CEO Kimberly K. Ryan. A Form 4 reports a charitable donation of 1,562 shares of common stock on 10/28/2025 using transaction code G. The reported transaction price was $0, consistent with a gift.
Following the donation, Ryan’s directly held beneficial ownership is 174,003.745 shares. The filing notes the shares were donated as a charitable contribution.
Hillenbrand director Gary L. Collar was granted a total of 295 Restricted Stock Units (RSUs) on 09/30/2025 across previously established deferred stock award schedules. Each RSU represents the contingent right to receive one share of Hillenbrand common stock and accrues dividend equivalents on record dates. Several of the RSU tranches vest immediately but delivery is restricted until a change in control, the director's death or disability, or one day after the director ceases to serve; other tranches vest on the earlier of the next annual meeting or one year from grant and are subject to the same delivery conditions. All reported RSUs are held in direct beneficial ownership form following the transactions.
Neil S. Novich, a director of Hillenbrand, Inc. (HI), reported acquisitions of 543 restricted stock units (RSUs) on 09/30/2025 tied to past director awards and deferred fees. Each RSU represents a contingent right to one share and accrues dividend equivalents. Several RSU tranches vested immediately on grant while others vest at the next annual meeting or within one year; certain awards convert to shares on retirement. The reported acquisitions were issued at $0 as compensation and increase Mr. Novich's direct beneficial ownership in the company.
Hillenbrand director Stuart A. Taylor II reported receipt of multiple restricted stock unit awards on 09/30/2025. The Form 4 shows the grant or conversion of a total of 696 restricted stock units (RSUs) across awards dated from 2/11/2009 through 2/18/2025, plus 93 shares from deferred director fees, resulting in reported beneficial ownership line items ranging up to 12,863 shares on the final line.
The filing explains that each RSU represents a contingent right to one share, that RSUs carry dividend equivalents, and that vesting or delivery rules vary by grant date (some vest immediately, others vest at the next annual meeting or one year, and certain awards convert to shares on the director's retirement). The Form 4 was signed by an attorney-in-fact on behalf of Mr. Taylor on 10/02/2025.
Nicholas R. Farrell, Sr. VP, GC & Secretary of Hillenbrand, Inc. (HI), reported transactions on 09/30/2025 in a Form 4 filing. The filing shows a disposition of 69,299 shares of common stock (Code V) and multiple entries recording the acquisition/vesting or grant of Restricted Stock Units (RSUs) totaling reported underlying shares: 12, 36, 83, 59, and 11,501. Following those RSU entries, the filing lists beneficially owned share counts of 1,508, 4,451, 10,174, 7,192, and 11,501 respectively. The RSUs carry dividend equivalent rights and have specified vesting schedules and settlement mechanics, including matching RSUs under an Executive Share Match framework that vest in 2028 and may be settled in shares or cash. The Form 4 is signed by Allison A. Westfall, Attorney-in-Fact on 10/02/2025.
J. Michael Whitted, the company's Sr. VP, Strategy & Corp. Dev., filed a Form 4 reporting transactions dated 09/30/2025. The filing shows a disposition of 81,473 shares of Hillenbrand common stock reported in Table I. Table II reports multiple Restricted Stock Unit (RSU) awards recorded as acquisitions on 09/30/2025, including 14, 39, 299, 67, and 63 RSUs from prior awards and a separate entry for 10,798 Matching RSUs with a 10/01/2025 transaction date. The RSUs convert one-for-one into common shares and carry dividend equivalent rights; vesting schedules for each grant are disclosed, ranging from 12/7/2023 through 10/01/2028 depending on the award. The form is signed by an attorney-in-fact for Mr. Whitted on 10/02/2025.
Aneesha Arora, Sr. VP & Chief HR Officer of Hillenbrand, Inc. (HI), filed a Form 4 reporting transactions dated 09/30/2025. The filing shows a disposition of 18,320 shares of the issuer's common stock and continuing indirect ownership of 16,125 shares through The Arora Revocable Trust. The Form 4 was signed by an attorney-in-fact on 10/02/2025.
On the same date, Ms. Arora reported acquisition entries for restricted stock units (RSUs) tied to prior awards: 12 RSUs (Deferred Award 12/07/2022), 33 RSUs (Deferred Award 12/07/2023), 79 RSUs (Deferred Award 12/05/2024), and 153 RSUs (Matching RSU Framework 03/31/2025). These RSUs are each scheduled to vest according to the award schedules described in the filing and are entitled to dividend equivalents.
Megan A. Walke, listed as Interim CFO, VP, CC & CAO of Hillenbrand, Inc. (HI), reported transactions dated 09/30/2025. The filing shows a disposition of 4,966 shares of common stock and the vesting/acquisition of restricted stock units from three deferred awards: 4 units (award dated 12/7/2022), 15 units (award dated 12/7/2023), and 27 units (award dated 12/5/2024), each representing a contingent right to one share. The RSUs carry dividend equivalent rights and have scheduled vesting in one‑third installments across the specified multi‑year schedules. The form is signed by an attorney‑in‑fact, Allison A. Westfall, dated 10/02/2025.
Jennifer W. Rumsey, a director of Hillenbrand, Inc. (HI), reported transactions dated 09/30/2025. The filing shows an indirect beneficial ownership of 587 shares through a revocable living trust and a disposition entry of 0 common shares. On 09/30/2025 Ms. Rumsey is recorded as acquiring a series of Restricted Stock Units from prior deferred awards: 5, 25, 23, 24, 26 and 34 RSUs (totaling 137 RSUs). The RSUs carry dividend equivalent rights and various vesting/delivery conditions: some vest immediately but delivery is deferred until a change in control, death, permanent disability, or termination of directorship; others vest on the earlier of the next annual meeting or one year from grant, with the same delivery deferral triggers. The form is signed by an attorney-in-fact on 10/02/2025.
Hillenbrand director Joseph T. Lower filed a Form 4 reporting changes in his beneficial ownership. On 09/30/2025 he was credited with 34 Restricted Stock Units (granted 02/18/2025) that represent the right to receive 34 shares of the issuer's common stock. Following the reported transaction he beneficially owned 4,122 shares of Hillenbrand common stock. The RSUs carry dividend equivalent rights and vest on the earlier of the next annual meeting or one year from grant, but they will become immediately vested on a change in control, the director's death or permanent total disability, or one day after he ceases to be a director. The Form 4 was signed by an attorney-in-fact on 10/02/2025.
Hillenbrand, Inc. director and Sr. VP & President, APS Ulrich Bartel filed a Form 4 disclosing transactions dated 09/30/2025. The filing reports a disposition of 24,179 shares of common stock (non-derivative) and the acquisition of restricted stock units (RSUs) settled in common shares on the same date. The RSU grants include 15, 46, 80, and 44 units from awards dated 12/7/2022, 12/7/2023, 12/5/2024, and 03/31/2025, respectively, with stated resulting beneficial ownership of 1,859, 5,637, 9,763, and 5,348 shares. The RSUs carry dividend equivalents and specified vesting schedules, including multi-year vesting tranches and a matching award that vests on 03/31/2028. The form is signed by an attorney-in-fact on behalf of Mr. Bartel on 10/02/2025.
Daniel C. Hillenbrand, a director of Hillenbrand, Inc. (HI), filed a Form 4 reporting transactions dated 09/30/2025. The filing shows a disposition of 3,448 shares of common stock. It also details multiple indirect beneficial holdings held through trusts and entities, including 20,000, 8,631, 28,248, 48,611, 135,863, and 5,754 shares attributed to various trusts and partnerships.
The filing also reports the grant/settlement of several Restricted Stock Units on 09/30/2025, with specific vested units of 9, 24, 36, 25, 23, 24, 26, and 34 units converting to beneficial ownership totals of 1,111, 2,942, 4,400, 3,099, 2,862, 2,913, 3,165, and 4,122 shares respectively. The RSUs carry dividend equivalent rights and varying vesting rules as explained in the filing.
Tamara Morytko, Sr. VP & President, MTS of Hillenbrand, Inc. (HI), reported changes in her holdings on a Form 4 covering transactions dated 09/30/2025 and 10/01/2025. The filing shows a disposition of 5,671 shares of common stock (Table I, Code V). It also records the settlement/conversion of multiple Restricted Stock Unit grants into common shares: 70, 39, 92, and 10 shares reported on 09/30/2025, and a 2,248-share settlement on 10/01/2025. Each RSU is shown with a $0 price reflecting settlement in shares, and the filing lists the post-transaction beneficial ownership totals for each grant line.
Bhavik N. Soni, Senior Vice President & Chief Information Officer of Hillenbrand, Inc. (HI), filed a Form 4 reporting several equity changes dated 09/30/2025 and signed 10/02/2025. The filing shows a disposition of 13,392 shares of Hillenbrand common stock and multiple acquisitions of Restricted Stock Units (RSUs) granted under prior award dates. The RSU entries record 5, 14, 25, 4, and 34 RSUs added to Mr. Soni's holdings, each settled in common stock and carrying dividend-equivalent rights.
The RSUs vest on specified schedules (one-third annual tranches for most awards) with one Matching RSU tied to the Executive Share Match framework vesting on March 31, 2028. After these transactions the filing reports updated beneficial ownership totals per award (for example 4,235 shares following the Matching RSU entry). The Form 4 discloses only the transactions and vesting schedules; no prices were paid for the RSUs and no additional commentary is included.
Kimberly K. Ryan, listed as President & CEO and a Director of Hillenbrand, Inc. (HI), reported transactions with an earliest transaction date of 09/30/2025. The filing shows a reported disposition of 175,565.745 shares of common stock (Code V), reducing her direct holdings. On the same date she acquired several restricted stock unit awards that convert into common shares: 83, 237, 432, and 312 RSUs, which correspond to 10,116, 28,788, 52,423, and 37,829 shares beneficially owned following each reported award, respectively. Vesting schedules and the matching RSU framework are disclosed in the filing.
Dennis W. Pullin, a director of Hillenbrand, Inc. (HI), reported acquisitions of restricted stock units on 09/30/2025. The Form 4 shows five separate deferred restricted stock unit awards tied to grant dates of 5/7/21, 2/10/22, 2/24/23, 2/20/24, and 2/18/25, resulting in additions of 9, 23, 24, 26, and 34 units respectively (totaling 116 RSUs). Each RSU represents the right to receive one share and carries dividend equivalent rights. The RSUs vest on the earlier of the next annual meeting or one year from grant but accelerate upon a change in control, the director’s death or permanent disability, or one day after the director ceases to be a director. The filing was signed by an attorney-in-fact on 10/02/2025.
Joy M. Greenway, a director of Hillenbrand, Inc. (HI), was awarded a series of Restricted Stock Units on 09/30/2025. The Form 4 reports the acquisition of 368 RSUs across awards dated 2013–2025 (individual grant amounts: 21, 33, 33, 38, 27, 24, 24, 36, 25, 23, 24, 26, 34). Each RSU represents the right to one share and the awards carry dividend equivalent rights; the reported per-share price is $0 because these are compensation awards rather than market purchases.
The filing notes vesting rules: some older awards vest immediately but have post-service holding requirements, while more recent awards vest at the next annual meeting or one year from grant and include accelerated vesting on a change in control, death, or disability. The Form 4 was filed by an attorney-in-fact on behalf of Ms. Greenway and shows these transactions were reported as acquisitions of derivative securities that convert into common stock.
Carole Anne Phillips, Senior Vice President & Chief Procurement Officer of Hillenbrand, Inc. (HI), reported changes in beneficial ownership on 09/30/2025. The Form 4 shows the acquisition (settlement) of multiple Restricted Stock Units (RSUs): 4 RSUs from a 12/07/2022 award (bringing that award's underlying common stock total to 578 shares), 13 RSUs from a 12/07/2023 award (total 1,629 shares), 23 RSUs from a 12/05/2024 award (total 2,824 shares), and 23 Matching RSUs under the Executive Share Match framework (listed as 2,788 underlying shares). Each RSU represents the contingent right to one share and RSUs carry dividend equivalence where noted. The filing was signed by an attorney-in-fact on 10/02/2025.
Helen W. Cornell, a director of Hillenbrand, Inc. (HI), reported transactions dated 09/30/2025. The filing shows indirect beneficial ownership of 11,691 shares held by the Helen W. Cornell 2020 Irrevocable Trust and 1,500 shares held by the Helen W. Cornell Rev. Trust. On 09/30/2025 Ms. Cornell was credited with 490 Restricted Stock Units (RSUs) across awards dating from 2012 through 2025. Several RSU grants vest immediately or under short schedules and carry dividend-equivalent rights; vesting and share delivery are subject to the issuer’s holding rules and specified conditions such as the next annual meeting or one year from grant for certain awards. The form is signed by an attorney-in-fact on 10/02/2025.
Hillenbrand director Inderpreet Sawhney reported receipt of restricted stock units on 09/30/2025. The filing lists five deferred stock awards totaling 114 Restricted Stock Units (7, 23, 24, 26, and 34 units). Each unit represents a contingent right to one share of common stock and carries dividend equivalent rights. The units have zero purchase price and vest on the earlier of the next annual meeting or one year from grant, with immediate vesting if a change in control, the director's death or disability, or the director’s termination occurs.